News

Screen Breast Cancer Patients for Depression

Publish date: June 9, 2011

 

FROM THE ANNUAL MEETING OF THE AMERICAN PSYCHIATRIC ASSOCIATION

The study was sponsored by the National Institute of Mental Health, the National Cancer Institute, and the National Institute on Aging. Dr. Spiegel is an editorial advisory board member to this news organization. He reported no other relevant financial disclosures.

Pages

Recommended Reading

Bevacizumab Shows Promise for High-Risk Ovarian Cancer
MDedge Hematology and Oncology
Bevacizumab Halves Progression Risk in Recurrent Ovarian Cancer
MDedge Hematology and Oncology
Survey Highlights Survivor Care Issues
MDedge Hematology and Oncology
BRAF Inhibitor Cuts Death Risk in Advanced Melanoma
MDedge Hematology and Oncology
Ipilimumab Added to Dacarbazine Prolongs Survival for Metastatic Melanoma
MDedge Hematology and Oncology
Longer Imatinib Therapy Improves Outcomes For High-Risk GIST
MDedge Hematology and Oncology
Pemetrexed Continuation Maintenance Slows NSCLC Progression
MDedge Hematology and Oncology
EBUS Equals Mediastinoscopy for NSCLC Staging
MDedge Hematology and Oncology
Carboplatin Adds No Benefit to Standard Therapy for Basal-Like Breast Cancer
MDedge Hematology and Oncology
Positive Data on Alpharadin Could Accelerate Filing Timeline
MDedge Hematology and Oncology